Your browser doesn't support javascript.
loading
In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database.
Saint-Lary, Laura; Diallo, Alpha; de Monteynard, Laure-Amélie; Paul, Christelle; Marchand, Lucie; Tubiana, Roland; Warszawski, Josiane; Mandelbrot, Laurent; Rekacewicz, Claire; Petrov-Sanchez, Ventzislava; Faye, Albert; Sibiude, Jeanne; Dabis, François; Sommet, Agnès; Leroy, Valériane.
Afiliação
  • Saint-Lary L; CERPOP, Inserm, Université de Toulouse, Université Paul Sabatier III, Toulouse, France.
  • Diallo A; Clinical Trial Safety and Public Health, ANRS, Paris, Île-de-France, France.
  • de Monteynard LA; International Research and Collaboration Unit, ANRS, Paris, Île-de-France, France.
  • Paul C; Clinical Trial Safety and Public Health, ANRS, Paris, Île-de-France, France.
  • Marchand L; Clinical and Therapeutic Research on HIV and Hepatitis Unit, ANRS, Paris, Île-de-France, France.
  • Tubiana R; University Hospital Pitié Salpêtrière Infectious and Tropical Diseases Service, Sorbonne Université, Inserm UMR-1136 Pierre Louis Institute of Epidemiology and Public Health, Paris, Île-de-France, France.
  • Warszawski J; Hospital Louis-Mourier, Obstetrics-Gynecology Department, Colombes CESP, Inserm U1018 Université Paris Diderot Risks in Pregnancy University Department, Colombes, Île-de-France, France.
  • Mandelbrot L; Hospital Louis-Mourier, Service de Gynécologie-Obstétrique, Institut national de la santé et de la recherche médicale Iame-U1137, Université Paris-Diderot, Colombes, Île-de-France, France.
  • Rekacewicz C; International Research and Collaboration Unit, ANRS, Paris, Île-de-France, France.
  • Petrov-Sanchez V; Clinical and Therapeutic Research on HIV and Hepatitis Unit, ANRS, Paris, Île-de-France, France.
  • Faye A; Robert-Debré Mother-Child University Hospital Division of Paediatric Medicine, Université Paris 7 Denis Diderot, Sorbonne Paris Cité, Inserm U1123, Paris, Île-de-France, France.
  • Sibiude J; Maternité Port-Royal, Département Hospitalier Universitaire Risques et Grossesse, Inserm U1018, Paris, Île-de-France, France.
  • Dabis F; Clinical Trial Safety and Public Health, ANRS, Paris, Île-de-France, France.
  • Sommet A; Inserm U1219, University of Bordeaux, ISPED, Bordeaux Population Health Research Center, Bordeaux, France.
  • Leroy V; CERPOP, Inserm, Université de Toulouse, Université Paul Sabatier III, Toulouse, France.
Br J Clin Pharmacol ; 88(3): 942-964, 2022 03.
Article em En | MEDLINE | ID: mdl-34505718
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores de Integrase de HIV / Fármacos Anti-HIV Limite: Female / Humans / Pregnancy Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores de Integrase de HIV / Fármacos Anti-HIV Limite: Female / Humans / Pregnancy Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França